Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 2OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 15Leukemia 15Leukemia, Myelomonocytic, Acute 10Leukemia, Monocytic, Acute 10Leukemia, Erythroblastic, Acute 10Leukemia, Megakaryoblastic, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Congenital Abnormalities 7Prostatic Neoplasms 6Breast Neoplasms 6Myelodysplastic Syndromes 4Anemia, Refractory, with Excess of Blasts 4Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Burkitt Lymphoma 2Sarcoma, Myeloid 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cytarabine 11tipifarnib 4Idarubicin 4Etoposide 4Sorafenib 3Bortezomib 3tanespimycin 2laromustine 2alvocidib 2Peripheral Blood Stem Cell Transplantation 2Mitoxantrone 2Gene Expression Profiling 2Daunorubicin 2DNA Methylation 2Busulfan 2Azacitidine 2valspodar 1romidepsin 1ixabepilone 1fludarabine phosphate 1entinostat 1aldesleukin 1XK 469 1Watchful Waiting 1Vorinostat 1Observation 1Microarray Analysis 1Melphalan 1Lenalidomide 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Leukemia, Eosinophilic, Acute × Mitoxantrone × Clear all
NCT01260714 2015-08-20

Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 1 Terminated
13 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT00407966 2015-08-04

Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
45 enrolled 7 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡